|
ELAV Proteins
|
D12.776.664.962.813.500 |
|
|
Receptors, Purinergic P2
|
D12.776.543.750.720.700.720 |
|
|
Pasteurellosis, Pneumonic
|
C08.730.085.600 |
|
|
Dolichol Monophosphate Mannose
|
D09.894.680.700.250 |
|
|
Retinal Neoplasms
|
C04.588.364.818 |
|
|
Eye Neoplasms
|
C04.588.364 |
|
|
Thrombasthenia
|
C16.320.099.820 |
|
|
Blood Coagulation Disorders, Inherited
|
C16.320.099 |
|
|
Ocular Hypertension
|
C11.525 |
|
|
Ribonucleoproteins, Small Nucleolar
|
D12.776.664.962.500.875.590 |
|
|
Harmala Alkaloids
|
D03.633.100.473.402.222 |
|
|
Shoulder Dislocation
|
C05.550.518.750 |
|
|
Joint Dislocations
|
C05.550.518 |
|
|
Osteogenesis Imperfecta
|
C05.116.099.708.685 |
|
|
Native Polyacrylamide Gel Electrophoresis
|
E05.196.401.402.625 |
|
|
Electrophoresis, Polyacrylamide Gel
|
E05.196.401.402 |
|
|
Military Family
|
F01.829.263.435 |
|
|
Cote d'Ivoire
|
Z01.058.290.190.272 |
|
|
Leucine-Responsive Regulatory Protein
|
D12.776.930.386 |
|
|
Change Management
|
D000078003 |
[Processes, tools, and techniques involved in the management of ORGANIZATIONAL INNOVATION, the purpose of which is to help individuals and work groups make successful personal transitions which ensure overall successful outcomes.
] |
